FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2240861563> ?p ?o ?g. }

• W2240861563 endingPage "e101" @default.
• W2240861563 startingPage "e81" @default.
• W2240861563 abstract "Sorafenib is a new multikinase inhibitor; the incidence of hypertension (HTN) with sorafenib has been reported to vary substantially among clinical trials. We searched multiple databases to investigate the risk of sorafenib-induced HTN in patients with cancer. A total of 93 trials involving 20,494 patients were selected for this meta-analysis. The relative risks (RRs) of all-grade and high-grade HTN associated with sorafenib were 3.06 ( P < 0.001) and 3.33 ( P < 0.001). There are no significantly RRs of all-grade, 0.81 ( P = 0.047), and high-grade HTN, 0.64 ( P = 0.075), in sorafenib monotherapy versus other multitargeted antiangiogenic tyrosine kinase inhibitors. The incidence of sorafenib-associated all-grade and high-grade HTN was 21.3% ( P < 0.001) and 5.9% ( P < 0.001), respectively. The patients with renal cell carcinoma (RCC) and thyroid cancer have high incidence (≥20%) of sorafenib-associated all-grade HTN and high incidence (≥5%) of sorafenib-associated high-grade HTN. The trials with median treatment duration ≥ 4, 5, and 7 months were 21.0% ( P < 0.001), 25.4% ( P < 0.001), and 27.6% ( P < 0.001); progression-free survival ≥ 6, 9, and 12 months were 24.5% ( P < 0.001), 26.8% ( P < 0.001), and 32.8% ( P < 0.001); and overall survival ≥ 12, 18, and 24 months were 18.5% ( P < 0.001), 22.5% ( P < 0.001), and 25.9% ( P < 0.001), respectively. There is a significantly high risk of sorafenib-induced HTN. In comparison between sorafenib and other multitargeted antiangiogenic tyrosine kinase inhibitors, RRs had no significance. The patients with RCC and thyroid cancer have significantly higher incidence of HTN. With prolonged treatment duration, progression-free survival, and overall survival, the incidence of all-grade HTN may increase." @default.
• W2240861563 created "2016-06-24" @default.
• W2240861563 creator A5010898353 @default.
• W2240861563 creator A5017096513 @default.
• W2240861563 creator A5036316294 @default.
• W2240861563 creator A5063417263 @default.
• W2240861563 creator A5068097751 @default.
• W2240861563 date "2017-01-01" @default.
• W2240861563 modified "2023-10-17" @default.
• W2240861563 title "Risk of Hypertension With Sorafenib Use in Patients With Cancer: A Meta-Analysis From 20,494 Patients" @default.
• W2240861563 cites W1495629113 @default.
• W2240861563 cites W1518372007 @default.
• W2240861563 cites W1523284208 @default.
• W2240861563 cites W1525365346 @default.
• W2240861563 cites W1544142122 @default.
• W2240861563 cites W1547252551 @default.
• W2240861563 cites W1559511540 @default.
• W2240861563 cites W1562056707 @default.
• W2240861563 cites W1568316544 @default.
• W2240861563 cites W1585969896 @default.
• W2240861563 cites W1604740730 @default.
• W2240861563 cites W1928548769 @default.
• W2240861563 cites W1947531983 @default.
• W2240861563 cites W1965024282 @default.
• W2240861563 cites W1965874702 @default.
• W2240861563 cites W1971837077 @default.
• W2240861563 cites W1972739162 @default.
• W2240861563 cites W1978580856 @default.
• W2240861563 cites W1978732845 @default.
• W2240861563 cites W1983150990 @default.
• W2240861563 cites W1988262237 @default.
• W2240861563 cites W1989040551 @default.
• W2240861563 cites W1990563353 @default.
• W2240861563 cites W1991690125 @default.
• W2240861563 cites W1992191791 @default.
• W2240861563 cites W1994193851 @default.
• W2240861563 cites W1994327821 @default.
• W2240861563 cites W1994606873 @default.
• W2240861563 cites W1996229105 @default.
• W2240861563 cites W1998499610 @default.
• W2240861563 cites W2003466422 @default.
• W2240861563 cites W2003566330 @default.
• W2240861563 cites W2012492706 @default.
• W2240861563 cites W2020452028 @default.
• W2240861563 cites W2025549295 @default.
• W2240861563 cites W2029870222 @default.
• W2240861563 cites W2031130345 @default.
• W2240861563 cites W2033585778 @default.
• W2240861563 cites W2034048944 @default.
• W2240861563 cites W2034158072 @default.
• W2240861563 cites W2038501887 @default.
• W2240861563 cites W2040474372 @default.
• W2240861563 cites W2046000826 @default.
• W2240861563 cites W2054669958 @default.
• W2240861563 cites W2057902408 @default.
• W2240861563 cites W2061345986 @default.
• W2240861563 cites W2063432158 @default.
• W2240861563 cites W2064382705 @default.
• W2240861563 cites W2073400280 @default.
• W2240861563 cites W2076516630 @default.
• W2240861563 cites W2078416515 @default.
• W2240861563 cites W2084778105 @default.
• W2240861563 cites W2085529853 @default.
• W2240861563 cites W2085932739 @default.
• W2240861563 cites W2089902400 @default.
• W2240861563 cites W2092228974 @default.
• W2240861563 cites W2093433762 @default.
• W2240861563 cites W2095445965 @default.
• W2240861563 cites W2097038360 @default.
• W2240861563 cites W2099938880 @default.
• W2240861563 cites W2100661360 @default.
• W2240861563 cites W2103689170 @default.
• W2240861563 cites W2105464202 @default.
• W2240861563 cites W2106533048 @default.
• W2240861563 cites W2107440450 @default.
• W2240861563 cites W2108215406 @default.
• W2240861563 cites W2109400578 @default.
• W2240861563 cites W2109800555 @default.
• W2240861563 cites W2112716777 @default.
• W2240861563 cites W2115068822 @default.
• W2240861563 cites W2115457093 @default.
• W2240861563 cites W2119242310 @default.
• W2240861563 cites W2119358583 @default.
• W2240861563 cites W2119402609 @default.
• W2240861563 cites W2120484846 @default.
• W2240861563 cites W2120967735 @default.
• W2240861563 cites W2122724278 @default.
• W2240861563 cites W2123172787 @default.
• W2240861563 cites W2125174117 @default.
• W2240861563 cites W2125922540 @default.
• W2240861563 cites W2126263799 @default.
• W2240861563 cites W2126565162 @default.
• W2240861563 cites W2126970264 @default.
• W2240861563 cites W2127045236 @default.
• W2240861563 cites W2127385754 @default.
• W2240861563 cites W2127452722 @default.
• W2240861563 cites W2131006629 @default.
• W2240861563 cites W2131528383 @default.

• next